Tom Mather

Tom Mather is the Chief Strategy Officer and board member at MCAL Therapeutics Ltd, with a background in oculoplastic surgery and a Doctor of Medicine degree from Indiana University School of Medicine. He has founded and advised multiple pharmaceutical and medical device companies, including OphthaFund and Allysta Pharmaceuticals, and has invested in various healthcare startups such as MCAL Therapeutics and Premark Pharma. Tom Mather's career highlights include founding OphthaFund and serving as the Head of Oculoplastic Surgery at Ralph H. Johnson Veteran’s Administration Hospital, showcasing his expertise in the medical field and strategic leadership within the healthcare industry. His current role at MCAL Therapeutics as Chief Strategy Officer underscores his commitment to advancing therapeutics and medical innovations.